CliffBio
small molecule

FENTORA

FENTANYL CITRATE

Loss of exclusivity—loss of exclusivity
CompanyCephalon →See this company's full patent-cliff portfolio

Drug detail

Brand nameFENTORA
Active ingredientFENTANYL CITRATE
StrengthEQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET
RouteBUCCAL, SUBLINGUAL
ModalitySmall molecule
FDA approvalMarch 2007
Marketing statusDISCN

More from Cephalon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.